Fig. 7
From: Prognostic value of natural killer T cell related genes in acute myeloid leukemia
Construction and validation of risk score model for AML patients. (A) Distribution of risk scores and survival status of AML patients in TCGA. (B) Kaplan-Meier survival curves of AML patients stratified into high-risk and low-risk groups based on the risk score in TCGA. (C) Time-dependent ROC curves for the risk score model at 1 year, 3 years, and 5 years in TCGA. (D) Distribution of risk scores and survival status of AML patients in GSE37642. (E) Kaplan-Meier survival curves of AML patients stratified into high-risk and low-risk groups based on the risk score in GSE37642. (F) Time-dependent ROC curves for the risk score model at 1 year, 3 years, and 5 years in GSE37642. (G) The distribution of gene mutations between high-risk and low-risk groups